David is responsible for the RNA production efforts at Life Edit Therapeutics. He has expertise in high-throughput screening platforms and has a passion for developing RNA-based therapies. Before joining Life Edit, he worked at Prime Medicine and Vertex Pharmaceuticals.
He received a B.S. in Genetics and Cell Biology at UGA-Athens, a PhD at UNC-Chapel Hill and did his postdoc at Harvard Stem Cell Institute.
.svg)
.svg)
To rewrite the future by curing disease, making any edit, anywhere.
To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.
We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.
